Cutanogen Overview

  • Founded
  • 1997
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 2

Cutanogen General Information

Description

Provider of biotechnology services. The company focuses on products such as PermaDerm and has license to develop engineered skin substitutes that are used to treat patients with severe burns.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 3130 Highland Avenue
  • Suite 3420
  • Cincinnati, OH 45219
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cutanogen Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cutanogen‘s full profile, request access.

Request a free trial

Cutanogen Executive Team (2)

Name Title Board Seat Contact Info
Mark Buch President and Chief Executive Officer
You’re viewing 1 of 2 executive team members. Get the full list »